FIELD: biochemistry.
SUBSTANCE: invention relates to a compound of Formula I and to its pharmacologically acceptable enantiomers and stereoisomers, with RH being R-lipoic acid. The invention also relates to a pharmaceutical composition based on the specified compound of Formula I.
EFFECT: new compound and a pharmaceutical composition based on it have been obtained, which can be used in medicine for the treatment of xerostomia, dry mouth and dry mouth in Sjogren's syndrome.
Formula I
4 cl, 5 dwg
Authors
Dates
2021-06-07—Published
2017-04-19—Filed